Accretive Health appoints Robert Stanek and Alex Mandl to Board as independent Directors

– USA, IL – Accretive Health, Inc. (NYSE: AH), today announced the appointment of two new independent directors to its Board of Directors. Robert Stanek, former president and CEO of Catholic Health East, and Alex Mandl, non-executive chairman of Gemalto and former President, COO and CFO at AT&T, joined the Board effective November 11, 2013.

“Bob and Alex bring a wealth of experience to the Board as we continue to strengthen Accretive Health’s position at the forefront of improving the effectiveness and efficiency of healthcare providers,” said Steve Schuckenbrock, President and CEO, Accretive Health. “Bob understands first-hand the pressures our clients face as the healthcare industry moves toward value-based care. Alex’s operational and financial expertise will be invaluable in supporting Accretive’s initiatives to improve operational execution, enhance client satisfaction and drive future growth.”

Additionally, Mary Tolan, current chairperson of the board, notified the Board of Directors on November 11, 2013, that she will not stand for re-election to the Board at the company’s next annual meeting of shareholders.

“Accretive Health is an organization of dedicated and passionate professionals committed to their clients and the quest for enhanced quality and affordability in healthcare,” Tolan said. “I look forward to the company’s future success and contributions to healthcare innovation. With the addition of these two very accomplished directors and a great management team fully in place, I believe next year will be an ideal time for me to step down from my role as chairperson and director to pursue other business interests.”

About Robert V. Stanek

Robert V. Stanek served as president and chief executive officer of Catholic Health East (CHE) from 2003 until his retirement in 2010. During his tenure, CHE was one of the largest Catholic health systems in the United States, with ministries located in 11 eastern states from Maine to Florida. The System included 34 acute care and four long-term acute care hospitals, numerous long-term care, assisted living, behavioral health, and home health and hospice facilities, as well as continuing care retirement communities and several ambulatory and community-based health services.

Stanek joined CHE’s Senior Management Team in 1997 as executive vice president of the Mid-Atlantic Division and then served as chief operating officer. He was promoted in 2003 to become the health system’s second president and chief executive officer. While at CHE, some of Stanek’s achievements included the realization of system synergies and efficiencies through shared IT, supply chain and financial services; a system-wide focus on clinical transformation and developing a person-centered system of care; and the development of CHE’s Preferred Health Care Delivery Model for 2017, among others.

Prior to joining CHE, Stanek served in a variety of capacities with the Mercy Health System of Western New York from 1992 to 1997, including president and chief executive officer, as well as chief operating officer/care delivery services. Before 1992, Stanek served in a number of administrative positions with the Daughters of Charity health care facilities in Pennsylvania and Virginia.

Stanek was elected to the board of trustees of the Catholic Health Association of the United States (CHAUSA) in 2006, which is the largest association of Catholic not-for-profit health care providers in the nation. Stanek earned a bachelor of arts degree in chemistry from East Stroudsburg University in East Stroudsburg, Pa.; a B.S. in pharmacy from the Philadelphia College of Pharmacy and Science; and an M.B.A. in administrative management from St. Joseph’s University, Philadelphia, Pa.

About Alex J. Mandl

Alex Mandl is currently the non-executive chairman of Gemalto, a company resulting from the merger between Gemplus International S.A. and Axalto Holding N.V. From June 2006 until December 2007, Mandl served as executive chairman of Gemalto. Before the merger, Mandl was president, CEO, and a member of the Board of Directors of Gemplus, positions he held since 2002. Prior to that, he was a principal in ASM Investments, and chairman and CEO of Teligent, a company he started in 1996.

From 1991 to 1996, Mandl was with AT&T, where he served as President and Chief Operating Officer with responsibility for long distance, wireless, local communications and internet services. Prior to his President/COO position, he was AT&T’s Chief Financial Officer. Mandl held various leadership positions in the transportation industry before joining AT&T. He began his career in 1969 at Boise Cascade Corp.

Mandl currently serves on the Boards of Gemalto, Arise Virtual Solutions and Genpact Limited. He also served on the Dell Inc. Board of Directors in several capacities, including Lead Director.

He holds an M.B.A. from the University of California at Berkeley and a B.A. in economics from Willamette University in Salem, Oregon.

About Accretive Health

At Accretive Health, our mission is to partner with healthcare communities to serve as a catalyst for a healthier future for all.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.